Published on in Vol 11 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/42458, first published .
Barriers and Opportunities for the Use of Digital Tools in Medicines Optimization Across the Interfaces of Care: Stakeholder Interviews in the United Kingdom

Barriers and Opportunities for the Use of Digital Tools in Medicines Optimization Across the Interfaces of Care: Stakeholder Interviews in the United Kingdom

Barriers and Opportunities for the Use of Digital Tools in Medicines Optimization Across the Interfaces of Care: Stakeholder Interviews in the United Kingdom

Journals

  1. Chaudhry I, Ghassani A, Wray J, Chaudhry B, Coats L. Outpatient care of adults with congenital heart disease in the UK: a qualitative appraisal of the clinician perspective. Open Heart 2024;11(1):e002420 View
  2. Camacho E, Gavan S, Keers R, Chuter A, Elliott R. Estimating the impact on patient safety of enabling the digital transfer of patients’ prescription information in the English NHS. BMJ Quality & Safety 2024:bmjqs-2023-016675 View
  3. Dinh T, Hanf M, Klein A, Brueckle M, Rietschel L, Petermann J, Brosse F, Schulz-Rothe S, Klasing S, Muth C, Seidling H, Engler J, Mergenthal K, Voigt K, van den Akker M, Titi M. Informational continuity of medication management in transitions of care: Qualitative interviews with stakeholders from the HYPERION-TransCare study. PLOS ONE 2024;19(4):e0300047 View